Community Acquired Pneumonia Flashcards

1
Q

What are common bacterial respiratory diseases associated with HIV?

A

Sinusitis, bronchitis, otitis, pneumonia

These diseases occur with increased frequency at all CD4 counts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the focus of the chapter on community-acquired pneumonia (CAP) in people with HIV?

A

Diagnosis, prevention, and management of bacterial CAP

Viral pneumonias like influenza and SARS-CoV-2 are outside the scope of these guidelines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is considered an AIDS-defining condition regarding pneumonia?

A

Recurrent pneumonia (two or more episodes within a 1-year period)

Bacterial pneumonia is a common cause of HIV-associated morbidity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How has the incidence of bacterial pneumonia in individuals with HIV changed with ART?

A

Decreased from 22.7 to 9.1 episodes per 100 person-years

This decline occurred after the introduction of ART.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the main risk factors for bacterial pneumonia in individuals with HIV?

A
  • CD4 count <100 cells/mm3
  • Lack of ART
  • Chronic viral hepatitis
  • Tobacco and alcohol use
  • Injection drug use
  • Chronic obstructive pulmonary disease (COPD)
  • Malignancy
  • Renal insufficiency
  • Congestive heart failure
  • Obesity

These factors contribute to the higher risk of pneumonia despite ART.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the most frequently identified bacterial causes of CAP in individuals with HIV?

A
  • Streptococcus pneumoniae
  • Haemophilus species
  • Staphylococcus aureus

Atypical pathogens like Legionella pneumophila and Mycoplasma pneumoniae are less common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What should be considered when diagnosing pneumonia in individuals with HIV?

A

Tuberculosis (TB) diagnosis

High incidence areas should always consider TB as a potential diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the significance of Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) in individuals with HIV?

A

Higher frequency as community-acquired pathogens

Risk factors include advanced HIV disease, corticosteroid use, and recent hospitalization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What clinical symptoms are characteristic of bacterial pneumonia in individuals with HIV?

A
  • Fever
  • Chills
  • Chest pain
  • Cough with purulent sputum
  • Dyspnea

These symptoms typically have an acute onset over 3 to 5 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the relationship between CD4 count and bacteremia in individuals with HIV?

A

Increased incidence of bacteremia with lower CD4 counts

Particularly significant with counts <100 cells/mm3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors are associated with increased mortality in individuals with HIV and pneumonia?

A
  • CD4 count <100 cells/mm3
  • Radiographic progression of disease
  • Presence of shock

These factors are independent predictors of increased mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the recommended diagnostic evaluation for CAP in hospitalized patients with HIV?

A
  • Gram stain of sputum
  • Two blood cultures

Especially for those with severe pneumonia or low CD4 counts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

True or False: The use of Procalcitonin (PCT) testing is recommended for guiding treatment decisions in HIV-associated bacterial pneumonia.

A

False

Specific PCT thresholds for HIV-associated pneumonia have not been established.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fill in the blank: The clinical diagnosis of bacterial pneumonia requires a demonstrable infiltrate by _______ or other imaging technique.

A

chest radiograph

This should be in conjunction with compatible clinical symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the potential long-term outcomes associated with pneumonia in individuals with HIV?

A
  • Greater long-term mortality
  • Impaired lung function
  • Increased risk of subsequent lung cancer

Hospitalization for pneumonia has been linked to increased mortality up to one year later.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the recommendation for routine diagnostic tests in outpatients with HIV and CAP?

A

Optional, especially if microbiologic studies cannot be performed promptly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What diagnostic tests are recommended for hospitalized patients with HIV and severe CAP?

A

Gram stain of sputum and two blood cultures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When should specimens for diagnostic tests be ideally obtained in patients with HIV?

A

Before initiation of antibiotics or within 12 to 18 hours after initiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What urinary antigen tests are recommended in hospitalized patients with severe CAP?

A
  • L. pneumophila
  • S. pneumoniae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What additional testing should be performed for adults with severe CAP?

A

Culture for Legionella on selective media or nucleic acid amplification testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When should rapid MRSA nasal testing be performed?

A

In patients with risk factors for MRSA or in a high prevalence setting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the yield of sputum cultures in patients with HIV?

A

Identifies bacterial etiology in up to 30-40% of good quality specimens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What should be done in patients with pleural effusion and concern for empyema?

A

Diagnostic thoracentesis should be performed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the importance of pneumococcal vaccination in people with HIV?

A

Prevents bacterial pneumonia and invasive pneumococcal disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the recommendation for PPSV23 in patients with CD4 counts <200 cells/mm3?

A

Preferably deferred until CD4 count increases to >200 cells/mm3 while on ART.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What should be administered to all people with HIV during influenza season?

A

Immunization against influenza with inactivated, standard dose or recombinant vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What modifiable factors are associated with an increased risk of bacterial pneumonia?

A
  • Smoking cigarettes
  • Using injection drugs
  • Consuming alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the general approach to antibiotic treatment of CAP in patients with HIV?

A

Same basic principles as for patients without HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What factors guide the decision for outpatient treatment versus hospitalization for CAP?

A

Severity of illness, ability to take oral medications, adherence, and confounding factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What scoring systems can guide decisions regarding treatment location for CAP in people with HIV?

A
  • Pneumonia Severity Index (PSI)
  • CURB-65
  • ATS/IDSA severity criteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What should be considered when selecting empiric antibiotic therapy for patients with HIV?

A

Local resistance patterns, MRSA testing results, and individual patient risk factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the preferred antibiotics for outpatient CAP treatment in individuals with HIV?

A
  • Oral beta-lactam plus a macrolide
  • Respiratory fluoroquinolone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the preferred beta-lactam for outpatient CAP treatment?

A

High-dose amoxicillin or amoxicillin-clavulanate.

34
Q

What is the role of TMP-SMX in preventing bacterial respiratory infections in HIV patients?

A

Should not be prescribed solely to prevent bacterial respiratory infection.

35
Q

What factors are associated with decreased risk of bacterial pneumonia in HIV patients?

A
  • Use of ART
  • TMP-SMX for PCP prophylaxis
36
Q

What are the considerations for using respiratory fluoroquinolones in patients with suspected TB?

A

Use with caution as it may delay proper TB diagnosis and treatment.

37
Q

What clinical trial demonstrated the efficacy of PCV against vaccine-type IPD in adults with HIV?

A

A trial on 7-valent PCV (PCV7) in Malawi showed 74% efficacy.

38
Q

What is the significance of CD4 count in the management of patients with HIV and CAP?

A

CD4 count <200 cells/mm3 is associated with increased risk of death.

39
Q

What additional vaccines are recommended for people with HIV?

A

COVID-19 vaccination and H. influenzae type vaccine if indicated.

40
Q

What are the preferred beta-lactams for outpatient CAP?

A

High-dose amoxicillin or amoxicillin-clavulanate

Alternatives include cefpodoxime or cefuroxime.

41
Q

What are the preferred macrolides for outpatient CAP?

A

Azithromycin or clarithromycin

42
Q

What should be used as an alternative to beta-lactam for patients allergic to penicillin?

A

A respiratory fluoroquinolone (moxifloxacin or levofloxacin)

43
Q

What should be given to patients with contraindications to a macrolide or fluoroquinolone?

A

Doxycycline in addition to a beta-lactam

44
Q

Why is empirical monotherapy with a macrolide not recommended for outpatient CAP in patients with HIV?

A

Due to increasing rates of pneumococcal resistance and potential treatment failure

45
Q

What is the recommendation for non-severe CAP inpatient treatment?

A

IV beta-lactam plus a macrolide or respiratory fluoroquinolone

46
Q

What has been found regarding beta-lactam monotherapy versus beta-lactam/macrolide combination therapy?

A

Beta-lactam monotherapy was not found to be non-inferior to combination therapy

47
Q

What are the preferred beta-lactams for inpatient treatment of non-severe CAP?

A

Ceftriaxone, cefotaxime, or ampicillin-sulbactam

48
Q

What should be used in patients who are allergic to penicillin?

A

A respiratory fluoroquinolone (moxifloxacin or levofloxacin)

49
Q

What is the treatment recommendation for severe CAP?

A

IV beta-lactam plus azithromycin or a respiratory fluoroquinolone

50
Q

What are the preferred beta-lactams for severe CAP treatment?

A

Ceftriaxone, cefotaxime, or ampicillin-sulbactam

51
Q

What should be added for patients with risk factors for Pseudomonas infection?

A

An antipneumococcal, antipseudomonal beta-lactam plus ciprofloxacin or levofloxacin

52
Q

What is the recommendation for empiric coverage for MRSA in patients with risk factors?

A

Vancomycin or linezolid should be added to the regimen

53
Q

What should be done when the etiology of pneumonia is identified?

A

Antimicrobial therapy should be modified and directed at the identified pathogen

54
Q

When should a switch to oral therapy be considered?

A

In patients with CAP on IV therapy who have improved clinically and can tolerate oral medications

55
Q

When should ART be initiated in patients with bacterial pneumonia not already on treatment?

A

Promptly within 2 weeks of initiating therapy for pneumonia

56
Q

What is a predictor for longer time to clinical stability in CAP patients with HIV?

A

Advanced HIV infection and CD4 count <100 cells/mm3

57
Q

What is the recommendation regarding pneumococcal and influenza vaccines for patients with HIV?

A

Patients should receive both vaccines as recommended

58
Q

What should be avoided to prevent recurrences of bacterial respiratory infections?

A

Antibiotic chemoprophylaxis

59
Q

What is the recommendation regarding smoking cessation for patients with pneumonia?

A

Patients should be encouraged to quit smoking

60
Q

What macrolide is recommended for use during pregnancy?

A

Azithromycin

61
Q

What is the recommendation for using quinolones during pregnancy?

A

Use only when a safer alternative is not available

62
Q

Why is doxycycline not recommended during pregnancy?

A

Due to increased hepatotoxicity and staining of fetal teeth and bones

63
Q

What is the risk of birth defects or musculoskeletal abnormalities associated with quinolone use in pregnant women?

A

No increased risk found

Studies evaluating quinolone use in pregnant women did not find an increased risk of birth defects or musculoskeletal abnormalities.

64
Q

What antibiotic is not recommended for use during pregnancy due to hepatotoxicity and fetal teeth staining?

A

Doxycycline

Doxycycline is associated with increased hepatotoxicity and staining of fetal teeth and bones.

65
Q

What are the beta-lactam antibiotics associated with in pregnancy?

A

No teratogenicity or increased toxicity

Beta-lactam antibiotics have not been associated with teratogenicity or increased toxicity in pregnancy.

66
Q

What is the theoretical risk associated with aminoglycosides during pregnancy?

A

Fetal renal or eighth nerve damage

A theoretical risk exists, but documented cases in humans are limited.

67
Q

What should be avoided during the first trimester of pregnancy if alternate agents are available?

A

Telavancin

Use of telavancin should be avoided in the first trimester if alternate agents with more experience in use in pregnancy are available.

68
Q

What is a potential consequence of pneumonia during pregnancy?

A

Increased rates of preterm labor and delivery

Pneumonia during pregnancy is associated with increased rates of preterm labor and delivery.

69
Q

When should pregnant women with pneumonia be monitored for evidence of contractions?

A

After 20 weeks’ gestation

Pregnant women with pneumonia after 20 weeks’ gestation should be monitored for evidence of contractions.

70
Q

What pneumococcal vaccines were found to be safe and immunogenic in pregnant women with HIV?

A

PCV10 and PPSV23

A study found that PCV10 and PPSV23 were equally safe and immunogenic in pregnant women with HIV.

71
Q

What vaccine is recommended for all pregnant women during influenza season?

A

Inactivated influenza vaccine

The inactivated influenza vaccine is recommended for all pregnant women during influenza season.

72
Q

What should be administered to pregnant women with HIV to minimize increases in plasma HIV RNA levels?

A

Vaccination after ART has been initiated

Vaccination of pregnant women is recommended after ART has been initiated to minimize increases in plasma HIV RNA levels.

73
Q

What should be administered to all people with HIV regardless of CD4 count?

A

Pneumococcal vaccination

All people with HIV regardless of CD4 count should receive pneumococcal vaccination.

74
Q

What should be administered at least 8 weeks after PCV15 for those without previous pneumococcal vaccination?

A

PPSV23

If PCV15 is used, a dose of PPSV23 should be administered at least 8 weeks later.

75
Q

What is the recommendation for adults age ≥65 regarding influenza vaccination?

A

High-dose IIV or adjuvanted IIV

Adults age ≥65 years are recommended to receive high-dose IIV or adjuvanted IIV over standard-dose unadjuvanted vaccine.

76
Q

What is the preferred outpatient therapy for community-acquired pneumonia?

A

An oral beta-lactam + a macrolide

Preferred therapy is an oral beta-lactam plus a macrolide (azithromycin or clarithromycin).

77
Q

What is the preferred therapy for hospitalized patients with non-severe community-acquired pneumonia?

A

An IV beta-lactam + a macrolide

The preferred therapy is an IV beta-lactam plus a macrolide (azithromycin or clarithromycin).

78
Q

What is the duration of therapy for most patients with community-acquired pneumonia?

A

5–7 days

The patient should be afebrile for 48–72 hours and clinically stable before discontinuation of therapy.

79
Q

What should be considered for patients who have improved and can tolerate oral medications?

A

Switch from IV to PO therapy

A switch should be considered for patients who have improved clinically, can swallow and tolerate oral medications.

80
Q

What is the recommendation regarding empiric therapy with a macrolide alone?

A

Not routinely recommended

Empiric therapy with a macrolide alone is not routinely recommended because of increasing pneumococcal resistance.